← Back to Clinical Trials
Recruiting NCT06235112
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
Trial Parameters
Condition Coronary Artery Disease
Sponsor Brigham and Women's Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 1,500
Sex ALL
Min Age 40 Years
Max Age 75 Years
Start Date 2024-07-31
Completion 2027-06-01
Interventions
Electronic health record-based notification of Nanox.AI Coronary Artery Calcification Assessment
Brief Summary
AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intelligence (AI) platform (Nanox.AI) that can analyze non contrast chest CT and estimate the amount of CAC.
Eligibility Criteria
Inclusion Criteria: * Patients aged between 40-75 with prior chest CT within last 3 years Exclusion Criteria: * Prior coronary artery disease * Prior cancer * Other life-limiting condition